Cargando…
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2
Enzymes that modify the epigenetic status of cells provide attractive targets for therapy in various diseases. The therapeutic development of epigenetic modulators, however, has been largely limited to direct targeting of catalytic active site conserved across multiple members of an enzyme family, w...
Autores principales: | Jayathilaka, Nimanthi, Han, Aidong, Gaffney, Kevin J., Dey, Raja, Jarusiewicz, Jamie A., Noridomi, Kaori, Philips, Michael A., Lei, Xiao, He, Ju, Ye, Jun, Gao, Tao, Petasis, Nicos A., Chen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384312/ https://www.ncbi.nlm.nih.gov/pubmed/22396528 http://dx.doi.org/10.1093/nar/gks189 |
Ejemplares similares
-
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
por: Di Giorgio, Eros, et al.
Publicado: (2020) -
Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling
por: Wales, Stephanie, et al.
Publicado: (2014) -
MEF/ELF4 transactivation by E2F1 is inhibited by p53
por: Taura, Manabu, et al.
Publicado: (2011) -
Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro
por: Voronova, Anastassia, et al.
Publicado: (2012) -
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription
por: Minisini, Martina, et al.
Publicado: (2022)